Antidepressants
(asked on 5th February 2025) - View Source
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if he will take steps with NHS England to review the (a) volume and (b) type of antidepressants prescribed on the NHS and their (i) side effects, (ii) long-term effectiveness and (iii) addictiveness.
The National Institute of Care and Excellence (NICE) and Medicines and Healthcare products Regulatory Agency (MHRA) are the relevant regulatory bodies in this area. While antidepressants can be helpful for some patients, NICE guidance recommends a range of non-drug options that should be considered first for people who present with less severe mental health conditions.
For patients diagnosed with depression, antidepressants are an effective treatment method. NICE has produced guidelines on antidepressants, which are available at the following link:
To ensure antidepressant drugs are made available to patients only where the benefits outweigh the potential harms, NHS England is encouraging integrated care boards to address inappropriate antidepressant prescribing and to consider commissioning services for patients wishing to reduce or stop antidepressants.
MHRA is leading a project to improve the information supplied with dependency-forming medicines. The project aims to improve risk minimisation measures and better inform and educate healthcare professionals and patients about the risk of dependence, addiction, tolerance, and withdrawal related to a wide range of medicines, including antidepressants in the United Kingdom.